Lonza to Buy Capsugel from KKR in Multibillion-Dollar Deal

Lonza said it had agreed to buy Capsugel, a New Jersey-based maker of drug capsules, from private-equity firm KKR in a deal valued at $5.5 billion including debt refinancing.

from WSJ.com: US Business http://ift.tt/2h3siXz
via IFTTT